Biohaven Pharmaceutical Holding Company and its wholly owned subsidiary, Biohaven Pharmaceuticals, has appointed Scott Phillips as senior vice president of finance. He will focus on further advancing Biohaven's infrastructure to support the company's accounting, external reporting and finance capabilities.
Phillips joins Biohaven, a clinical-stage biopharmaceutical company, with nearly 20 years of accounting and finance experience in both the pharmaceutical industry and public accounting practice. Most recently, he served as chief accounting officer, and then SVP of global business finance, at Alexion Pharmaceuticals.
At Alexion, Phillips was responsible for expanding the accounting organization and internal control structure from a pre-commercial business to a global accounting organization supporting over 50 countries. In these roles, his responsibilities included overseeing Alexion's accounting, SEC reporting, Sarbanes-Oxley Section 404 compliance, tax, shared services and financial planning and analysis functions. Prior to Alexion, Scott served as senior audit manager at PricewaterhouseCoopers.